Loading
Latest filing published 09 Sept 2009 for Stem Cell Therapy International, Inc., €42k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
David Stark discloses dealings in Stem Cell Therapy International, Inc. to SEC (Form 4). Between 11 December 2008 and 27 July 2009, the trades on record add up to 3 filings.
The open-market record is one-sided, with 2 purchases worth €722 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. So far in 2009, the count stands at 2 purchases and no sales.
Most recently, on 9 September 2009, the filings show a share grant worth €42k in Stem Cell Therapy International, Inc. The last purchase on record was published on 11 February 2009, which is 6,465 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations